Subscribe To
CFMS / Conformis' Q4 Miss Street View As Earnings Impacted By Surge In COVID-19 Cases
CFMS News
By Zacks Investment Research
May 8, 2023
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
ConforMIS (CFMS) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $2 more_horizontal
By GlobeNewsWire
April 13, 2023
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee more_horizontal
By Zacks Investment Research
March 6, 2023
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade
ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal
By Seeking Alpha
March 1, 2023
Conformis, Inc. (CFMS) Q4 2022 Earnings Call Transcript
Conformis, Inc. (NASDAQ:CFMS ) Q4 2022 Results Conference Call March 1, 2023 4:30 PM ET Company Participants Mark Augusti - President and Chief Execut more_horizontal
By GlobeNewsWire
January 23, 2023
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee a more_horizontal
By Seeking Alpha
November 2, 2022
Conformis, Inc. (CFMS) Q3 2022 Earnings Call Transcript
Conformis, Inc. (NASDAQ:CFMS ) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Mark Augusti - President and CEO Bob H more_horizontal
By Zacks Investment Research
November 2, 2022
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hol more_horizontal
By GlobeNewsWire
August 29, 2022
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee more_horizontal